Opening Remarks, Presidential & Program Chair Welcome
Speaker:
Jennifer Balkus, PhD, MPH (University of Washington)
9:00 AM - 10:15 AM
Fashion/Culture Ballroom
General Session 1
Moderator:
Jennifer Balkus, PhD, MPH (University of Washington)
9:00 AM - 10:15 AM
Gender-Affirming Care and Its Impacts on the Sexual and Reproductive Health of Transgender and Gender Diverse People Assigned Female Sex at Birth
Speakers:
Geolani Dy (Oregon Health & Science University) & Olivia Van Gerwen (University of Alabama at Birmingham)
10:15 AM - 10:45 AM
Cityview Living Room
Break
10:45 AM - 12:15 PM
Fashion/Culture Ballroom
Oral Abstract Session 1
Moderators:
Melissa Herbst-Kralovetz (University of Arizona) & Rebecca Howett (University of Washington)
10:45 AM - 11:00 AM
A Novel Multi-Strain Vaginal Synbiotic Is Effective in Optimizing the Vaginal Microbiome: Results From a Randomized, Placebo-Controlled Clinical Trial (#001)
Speaker:
Sheri Simmons (Seed Health)
11:00 AM - 11:15 AM
Vaginal Odor Is Associated With Increased Abundance of Prevotella, Megasphaera, Porphyromonas, and Finegoldia (#002)
Speaker:
Krystal Thomas-White (Evvy)
11:15 AM - 11:30 AM
Comparison of Endocervical Immune Cell Populations, Vaginal Microbiota and Mucosal Immune Response in Women Treated With Rituximab and Untreated Controls (#003)
Speaker:
Ofri Bar (Massachusetts General Hospital and The Hebrew University of Jerusalem)
11:30 AM - 11:45 AM
Modulation of Mucosal Glycans by the Vaginal Microbiome: A Risk Factor for Chlamydia Infection? (#004)
Speaker:
Katherine Heger (University of Calgary)
11:45 AM - 12:00 PM
Investigating Pathogenesis of Sneathia Species Using a Human 3D Cervical Model (#005)
Speaker:
Paweł łaniewski (University of Arizona College of Medicine – Phoenix)
12:00 PM - 12:15 PM
The Impact of Gender-Affirming Testosterone Therapy on the Vaginal Microbiota of Transgender Men and Non-binary People Assigned Female Sex at Birth (#006)
Speaker:
Olivia Van Gerwen (University of Alabama at Birmingham)
12:30 PM - 1:30 PM
Fashion/Culture Ballroom
Industry Sponsored Symposium 2
1:30 PM - 2:30 PM
Fashion/Culture Ballroom
Oral Abstract Session 2
Moderators:
Paul Wasuwanich (University of Florida College of Medicine) & Marisa R. Young (Department of Gynecology and Obstetrics, Emory University School of Medicine)
1:30 PM - 1:45 PM
National Perspectives of Youth: Evaluating Adolescents’ Attitudes Towards Self-Swabbing for Home-Based STI Testing (#007)
Speaker:
Theresa Rager (University of Michigan Medical School)
1:45 PM - 2:00 PM
Associations Between Relationship Dynamics and STI Expedited Partner Therapy Acceptance and Delivery Among Adolescent Girls and Young Women in Johannesburg, South Africa (#008)
Speaker:
Rebecca Howett (University of Washington)
2:00 PM - 2:15 PM
Nitazoxanide and Tizoxanide Demonstrate High Levels of in Vitro Activity Against Metronidazole-Susceptible and Metronidazole-Resistant Trichomonas Vaginalis Clinical Isolates (#009)
Speaker:
Keonte Graves (Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham)
2:15 PM - 2:30 PM
Testing for Gonorrhea and Chlamydia Among People With Opioid Use Disorder During Pregnancy (#010)
Speaker:
K. Meryl Davis (CDC Foundation)
2:30 PM - 3:15 PM
Fashion/Culture Ballroom
Stump the Professors
Professors:
Deborah Money, CM, BSc, MD, FRCSC, FCAHS (University of British Columbia), Christina Muzny, MD, MSPH (University of Alabama at Birmingham) & Neil Silverman, MD (David Geffen School of Medicine at UCLA)
2:30 PM - 2:50 PM
The Fast and Furious
Speaker:
Nathalie Chang (University of Texas Health Science Center San Antonio)
2:50 PM - 3:10 PM
Case Presentation
Speaker:
Noor Al-Shibli (Emory University School of Medicine)
3:30 PM - 4:30 PM
Design Ballroom
Poster Session 1
Home-Based STI Test Kits: Barriers to Use Among a Nationwide Cohort of Adolescents and Young Adults (#029)
Speaker:
Katie Foug (University of Michigan Medical School)
Pharmacokinetic and Safety Results From Two Phase 1 Studies of Oteseconazole in Women With Severe Renal Insufficiency Not Requiring Dialysis vs Normal Renal Function and Women With Moderate Hepatic Impairment vs Normal Hepatic Function (#044)
Speaker:
Stephen Brand (Mycovia Pharmaceuticals, Inc.)
Surveying Awareness of Human Papillomavirus in Nursing Staff (#049)
Speaker:
Eugenia Lee (Brigham and Women's Hospital)
Is Preterm Delivery Associated With Higher Likelihood of Systemic Infection in Patients With Post-cesarean Wound Infection? (#050)
Speaker:
Ashley Cummings (Duke University School of Medicine)
Association Between Socioeconomic Status and Maternal Risk Factors on the Likelihood and Severity of Medically Attended Respiratory Syncytial Virus–Lower Respiratory Tract Illness (#051)
Disparities in COVID-19 Vaccine Uptake Among Pregnant People in a Diverse Urban Population With High Vaccine Acceptance (#053)
Speaker:
Christine A. Blauvelt (University of California, San Francisco)
Improving Peri-Operative Antibiotic Management at the Time of Cesarean Delivery to Reduce Surgical Site Infections (SSI) in Women With Severe Postpartum Hemorrhage at a Single Institution (#054)
Speaker:
Bryce Beyer (University of Tennessee Medical Center)
Moderators:
Jennifer Balkus, PhD, MPH (University of Washington) & Neil Silverman, MD (David Geffen School of Medicine at UCLA)
8:30 AM - 9:30 AM
NIAID Perspective on Reproductive Tract Infections in Women
Speaker:
Jeanne Marrazzo (U.S. National Institutes of Health (NIH))
9:30 AM - 10:30 AM
Fashion/Culture Ballroom
Oral Abstract Session 3
Moderators:
Isabelle Boucoiran (University of Montreal) & Bolu Idowu (Vanderbilt University Medical Center)
9:30 AM - 9:45 AM
First-Trimester Antibiotic Treatments for Urinary Tract Infections and Risk of Congenital Malformations (#011)
Speaker:
Yanmin Zhu (Brigham and Women’s Hospital and Harvard Medical School)
9:45 AM - 10:00 AM
Placental Malaria Induces a Unique Placental Methylation Profile Associated With Fetal Growth Restriction (#012)
Speaker:
Nida Ozarslan (UCSF)
10:00 AM - 10:15 AM
Outcomes of Hepatitis B and Hepatitis Delta Co-infection in Hospitalized Pregnant Women in the United States: A Nationwide Study (#013)
Speaker:
Paul Wasuwanich (University of Florida College of Medicine)
10:15 AM - 10:30 AM
Doubling Down: Characteristics and Outcomes Associated With Discretionary Dosing of Penicillin Among People With Early Syphilis During Pregnancy (#014)
Speaker:
K. Meryl Davis (CDC Foundation)
10:30 AM - 11:00 AM
Cityview Living Room
Break
11:00 AM - 12:15 PM
Fashion/Culture Ballroom
Oral Abstract Session 4
Moderators:
Marissa Berry (The Ohio State University) & Neil Silverman, MD (David Geffen School of Medicine at UCLA)
11:00 AM - 11:15 AM
Antepartum Versus Postpartum Amoxicillin Oral Challenge in Penicillin-Allergic Pregnant Patients: A Two-Center Prospective Cohort Study (#015)
Speaker:
Jeffrey Man Hay Wong (University of British Columbia)
11:15 AM - 11:30 AM
Risk-Stratified Management to Remove Low-Risk Penicillin Allergy Labels During the Postpartum Hospitalization (#016)
Speaker:
Ann Tucker (Vanderbilt University Medical Center)
11:30 AM - 11:45 AM
A Retrospective Analysis of Obstetric Outcomes After the Implementation of Standardized Perinatal Sepsis Order Set (#017)
Speaker:
Nathalie Chang (University of Texas Health Science Center San Antonio)
11:45 AM - 12:00 PM
Clinical and Social Factors Influencing Respiratory Syncytial Virus (RSV) Vaccine Uptake in Pregnancy (#018)
Speaker:
Bolu Idowu (Vanderbilt University Medical Center)
12:00 PM - 12:15 PM
Uptake of the Respiratory Syncytial Virus (RSV) Vaccine and Nirsevimab Among Pregnant Patients and Their Neonates (#019)
Speaker:
Christine A. Blauvelt (University of California, San Francisco)
12:30 PM - 1:30 PM
Fashion/Culture Ballroom
Industry Sponsored Symposium 4
1:30 PM - 2:30 PM
Design Ballroom
Poster Session 2
A Novel Multi-Strain Vaginal Synbiotic Is Effective in Inhibiting Microbes Associated With Vaginal Dysbiosis, Inflammation, and Mucus Barrier Degradation (#055)
Speaker:
Sheri Simmons (Seed Health)
The Relationship Between Transportation Insecurity and Influenza Vaccination Among Pregnant Individuals in the US: An Opportunity for a Bundled Intervention (#056)
Speaker:
Jodian Pinkney (Massachusetts General Hospital)
Immunometabolic Impacts of Phthalates on the Urogenital Microenvironment of Reproductive Aged Women: A Pilot Study (#057)
Speaker:
Holly Chatenoud (University of Arizona College of Medicine – Phoenix, Phoenix, AZ and University of Bath, Bath, UK)
Technology for Sexual Health Equity: Reaching Vulnerable Communities in Maryland With Free, Self-Collected Sexually Transmitted Infection Testing (#058)
Speaker:
Camille Shantz (Johns Hopkins School of Medicine)
Economic Evaluation of a Nucleic Acid Amplification Test Panel for Diagnosis of Bacterial Vaginosis, Vulvovaginal Candidiasis, Trichomoniasis, and Mixed Infections Among Patients With Vaginitis Symptoms in the United States (US) (#030)
Investigating the Performance of Serum Biomarkers Used to Predict Preeclampsia in Patients With Acute Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (#072)
Speaker:
Carolynn Dude (Emory University School of Medicine, Endeavor/NorthShore Health System)
Understanding the Respiratory Syncytial Virus (RSV) Vaccine and Prevention Options
Speaker:
Haben Debessai (CDC Foundation)
7:00 PM - 11:00 PM
Fashion/Culture Ballroom
Awards Ceremony/Dinner Dance
Saturday, August 3, 2024
7:30 AM - 8:30 AM
Fashion/Culture Ballroom
Annual Business Meeting
8:30 AM - 9:45 AM
Fashion/Culture Ballroom
General Session 3
Moderator:
Jennifer Balkus, PhD, MPH (University of Washington)
8:30 AM - 9:45 AM
Syphilis Challenges and Opportunities: Prevention, Testing, and Treatment
Speakers:
Caroline Cameron (University of Victoria) & Kate Miele (Emory University’s Department of Gynecology and Obstetrics)
9:45 AM - 10:30 AM
Fashion/Culture Ballroom
Oral Abstract Session 5
Moderators:
Angela Boyd (UT Health San Antonio) & Christine Field (The Ohio State University)
9:45 AM - 10:00 AM
Group B Streptococcus Colonization and Chorioamnionitis Among Nulliparous Individuals in the nuMoM2B Cohort (#020)
Speaker:
Marissa Berry (The Ohio State University)
10:00 AM - 10:15 AM
Effects of Integrase Strand Transfer Inhibitors (INSTIs) Versus Non-INSTI Regimen Exposures on Pregnancy Outcomes, Maternal Weight Gain and HIV Viral Suppression (#021)
Speaker:
Fouzia Z.A. Khan (Johns Hopkins University School of Medicine)
10:15 AM - 10:30 AM
Cytomegalovirus Infection During Pregnancy: Comparison Between Women Living With and Without Human Immunodeficiency Virus (#022)
Speaker:
Isabelle Boucoiran (University of Montreal)
10:30 AM - 11:00 AM
Cityview Living Room
Break
11:00 AM - 12:30 PM
Fashion/Culture Ballroom
Oral Abstract Session 6
Moderators:
Sarah Boudova (Thomas Jefferson University) & Fouzia Z.A. Khan (Johns Hopkins University School of Medicine)
11:00 AM - 11:15 AM
Impact of the COVID-19 Pandemic on Existing Disparities in Congenital Syphilis Rates Across Los Angeles County (#026)
Speaker:
Elaine Chan (University of California, Los Angeles)
11:15 AM - 11:30 AM
A Randomized, Double-Blind, Placebo- And Active-Controlled, Parallel, Nested Crossover, QT Study of Oteseconazole in Healthy Women (#024)
Speaker:
Stephen Brand (Mycovia Pharmaceuticals, Inc.)
11:30 AM - 11:45 AM
Neighborhood Socioeconomic Disadvantage and Chorioamnionitis (#025)
Speaker:
Christine Field (The Ohio State University)
11:45 AM - 12:00 PM
Pilot Case Series of a Vaginal Cooling Device for the Treatment of Vulvovaginal Candidiasis (#023)
Speaker:
Kim Langdon (Coologics, Inc)
12:00 PM - 12:15 PM
Species-Specific Differences in Glycogen Utilization Associate With Lactic Acid Levels in the Vagina (#027)
Speaker:
Karen Lithgow (University of Calgary)
12:15 PM - 12:30 PM
Leveraging Machine Learning Techniques to Investigate the Pathogenesis of Incident Bacterial Vaginosis (#028)
Speaker:
Jacob Elnaggar (Department of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center)
12:30 PM - 12:35 PM
Fashion/Culture Ballroom
Wrap Up/Adjourn Meeting
Speaker:
Jennifer Balkus, PhD, MPH (University of Washington)